Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
NKF-FDA workshop reviews endpoints for studies of chronic kidney disease. |
NKF: After extensive analysis of data from observational cohorts and interventional trials, the workshop planning committee and attendees recommended a 30 or 40% decline in glomerular filtration rate (GFR) as new surrogate endpoints for some clinical trials in chronic kidney disease used for regulatory approval. |